Type of MS: PPMS|PRMS|RRMS|SPMS
Treatment mode of action: n/a
Number of Subjects: 100
Institutions: Open Medicine Institute
Katelyn Dallman, ext. 3004
Centers for Disease Control
This is an observational study looking at a symptomatic, immune function and inflammatory markers of disease with respect to fatiguing illnesses and their potential causes. Participants will be asked to fill out a set of questionnaires, contribute saliva and blood, and have a brief physical exam. Volunteers receive compensation for their time. Participants may be given the option to participate in a separate treatment study in 2021.
Participants should be aged 18-70 with a diagnosis of MS. Exclusion criteria are HIV, pregnancy, dementia, and present cancer (people who have had cancer in the past are not excluded).
If you live in these areas, and are interested in participating, please reach out to the contact above.
San Diego, CA
Los Angeles, CA
Ellicott City, MD
New York City, NY
Northern New Jersey